ofloxacin has been researched along with ru 66647 in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 13 (81.25) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sáez-Nieto, JA; Vázquez, JA | 1 |
| Bebear, C; Bebear, CM; Bryskier, A; Renaudin, H | 1 |
| Baltch, AL; Franke, MA; Michelsen, PB; Ritz, WJ; Smith, RP | 1 |
| Coleman, EJ; Mandell, GL | 1 |
| Ishii, Y; Miyazaki, S; Okamoto, H; Tateda, K; Yamaguchi, K | 1 |
| Andrasevic, AT; Appelbaum, PC; Davies, TA; Drukalska, L; Hoellman, DB; Hryniewicz, W; Hupkova, H; Jacobs, MR; Kelly, LM; Kolman, J; Miciuleviciene, J; Nagai, K; Pana, M; Setchanova, L; Thege, MK; Trupl, J; Urbaskova, P | 1 |
| Bercion, R; Carricajo, A; Celard, M; Chomarat, M; Croizé, J; Delubac, F; Fèvre, D; Frédénucci, I; Fuhrmann, C; Helfre, M; Lelièvre, H; Letouzey, MN; Mandjee, A; Marthelet, P; Meley, R; Perrier-Gros-Claude, JD; Ros, A; Roure, C; Smati, S; Thierry, J; Tous, J | 1 |
| Horcajada, JP; Martínez, JA | 1 |
| Bryskier, A; La Scola, B; Raoult, D | 1 |
| Caronzolo, D; Colleoni, F; Fraschini, F; Grosso, S; Lucini, V; Pannacci, M; Scaglione, F | 1 |
| Denys, GA; Kays, MB; Lisek, CR | 1 |
| Appelbaum, PC; Clark, CL; Ednie, LM; Kosowska-Shick, K | 1 |
| Chan, FK; Lee, CC; Lee, VW; Ling, TK | 1 |
| May, T | 1 |
| Castanheira, M; Jones, RN; Woosley, LN | 1 |
| Ishii, Y; Kimura, S; Sato, T; Tateda, K; Yamaguchi, K | 1 |
16 other study(ies) available for ofloxacin and ru 66647
| Article | Year |
|---|---|
In vitro activities of ketolides HMR 3647 [correction of HRM 3647] and HMR 3004 [correction of HRM 3004], levofloxacin, and other quinolones and macrolides against Neisseria spp. and Moraxella catarrhalis.
Topics: Anti-Bacterial Agents; Humans; Ketolides; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseria; Ofloxacin | 1999 |
Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmas.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Humans; Ketolides; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma Infections; Ofloxacin | 2000 |
Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila.
Topics: Anti-Bacterial Agents; Erythromycin; Humans; Ketolides; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Macrolides; Monocytes; Ofloxacin | 2000 |
Activities of antimicrobial agents against intracellular pneumococci.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Fluoroquinolones; Gentamicins; Humans; Ketolides; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Penicillin G; Quinolines; Rifampin; Streptococcus pneumoniae; Tumor Cells, Cultured | 2000 |
Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against gram-positive clinical isolates in Japan.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Gram-Positive Bacteria; Humans; Japan; Ketolides; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Respiratory Tract Infections; Staphylococcus aureus | 2000 |
Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 Pneumococci from 10 central and Eastern European countries.
Topics: Age Factors; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Bacterial; Europe; Gene Frequency; Humans; Ketolides; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Ribosomal Proteins; Serotyping; Streptococcus pneumoniae | 2002 |
Comparative in vitro activity of penicillin G, levofloxacin, moxifloxacin, telithromycin, pristinamycin, quinupristin-dalfopristin and linezolid against ofloxacin-intermediate and -resistant Streptococcus pneumoniae.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Ketolides; Lactams; Levofloxacin; Linezolid; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Oxazolidinones; Penicillin G; Pristinamycin; Quinolines; Streptococcus pneumoniae; Virginiamycin | 2002 |
[New antibiotics in primary care].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Family Practice; Fluoroquinolones; Ketolides; Macrolides; Moxifloxacin; Ofloxacin; Quinolines | 2003 |
Comparison of the in vitro efficacy of telithromycin (HMR 3647) and levofloxacin with 22 antibiotic compounds against Bosea and Afipia species.
Topics: Afipia; Alphaproteobacteria; Anti-Bacterial Agents; Ketolides; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Ofloxacin | 2004 |
Glucocorticoids increase in vitro and in vivo activities of antibiotics against Chlamydophila pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Cell Line; Chlamydophila Infections; Chlamydophila pneumoniae; Dexamethasone; Drug Synergism; Glucocorticoids; Humans; Ketolides; Levofloxacin; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Ofloxacin | 2004 |
Comparative in vitro and bactericidal activities of telithromycin against penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant Streptococcus pneumoniae by time-kill methodology.
Topics: Anti-Bacterial Agents; Humans; In Vitro Techniques; Ketolides; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 2007 |
Capability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologies.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Clindamycin; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Imipenem; Ketolides; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae | 2007 |
Levofloxacin-resistant Helicobacter pylori in Hong Kong.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA Gyrase; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Ketolides; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Point Mutation; Tetracycline | 2008 |
[New antibiotics].
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Ertapenem; Humans; Ketolides; Minocycline; Ofloxacin; Tigecycline; Virginiamycin | 2008 |
CEM-101 activity against Gram-positive organisms.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Gentamicins; Gram-Positive Bacteria; Ketolides; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2010 |
In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bridged-Ring Compounds; Cell Line; Cells, Cultured; Clarithromycin; Disease Models, Animal; Humans; Ketolides; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Macrolides; Mice; Microbial Sensitivity Tests; Ofloxacin | 2011 |